Toxicity of dopamine to striatal neurons in vitro and potentiation of cell death by a mitochondrial inhibitor

Journal of Neurochemistry

Volumn 70, Issue 6, 1998, Pages 2406-2415

  McLaughlin, B A ^a   Nelson, D ^a   Erecinska M ^a   Chesselet, M F ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Dopamine; Huntington's disease; Malonate; Methyl malonate; Mitochondria; Striatum

Indexed keywords

3 NITROPROPIONIC ACID; DOPAMINE; MALONIC ACID;

ANIMAL CELL; ARTICLE; CELL DEATH; HUNTINGTON CHOREA; MITOCHONDRION; NEUROTOXICITY; NONHUMAN; OXIDATIVE PHOSPHORYLATION; PRIORITY JOURNAL; RAT; STRIATE CORTEX; TRANSIENT ISCHEMIC ATTACK;

ANIMALIA; LETHRINIDAE;

EID: 0031776914     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1998.70062406.x     Document Type: Article

References (61)

1. Albers D. S., Zeevalk G. D., and Sonsalla P. K. (1996) Damage to dopaminergic nerve terminals in mice by combined treatment of intrastriatal malonate with systemic methamphetamine or MPTP. Brain Res. 718, 217-220.
2. Baker A. J., Zornow M. H., Scheller M. S., Yaksh T. L., Skilling S. R., Smullin D. H., Larson A. A., and Kuczenski R. (1991) Changes in extracellular concentrations of glutamate, aspartate, glycine, dopamine, serotonin, and dopamine metabolites after transient global ischemia in the rabbit brain. J. Neurochem. 57, 1370-1379.
3. Beal M. F. (1994) Huntington's disease, energy and excitotoxicity. Neurobiol. Aging 15, 275-276.
4. Beal M. F., Brouillet E., Jenkins B., Henshaw R., Rosen B., and Hyman B. T. (1993) Age-dependent striatal excitotoxic lesions produced by the endogenous mitochondrial inhibitor malonate. J. Neurochem. 61, 1147-1150.
5. Behrens M. I., Koh J., Canzoniero L. M., Sensi S. L., Csernansky C. A., and Choi D. W. (1995) 3-Nitropropionic acid induces apoptosis in cultured striatal and cortical neurons. Neuroreport 6, 545-548.
6. Ben-Shachar D., Zuk R., and Glinka Y. (1995) Dopamine neurotoxicity: inhibition of mitochondrial respiration. J. Neurochem. 64, 718-723.
7. Brennan W. A., Bird E. D., and Aprille J. R. (1985) Regional mitochondrial respiratory activity in Huntington's disease brain. J. Neurochem. 44, 1948-1950.
8. Brewer G. J., Torricelli J. R., Evege E. K., and Price P. J. (1993) Optimized survival of hippocampal neurons in B27 supplemented Neurobasal, a new serum-free medium combination. J. Neurosci. Res. 35, 567-576.
9. Brouillet E., Jenkins B. C., Hyman B. T., Ferrante R. J., Kowall N. W., Srivastava R., Roy D. S., Rosen B. R., and Beal M. F. (1993) Age-dependent vulnerability of the striatum to the mitochondrial toxin 3-nitropropionic acid. J. Neurochem. 60, 356-359.
10. Brouillet E., Hantraye P., Ferrante R. J., Dolan R., Leroy-Willig A., Kowall N. W., and Beal M. F. (1995) Chronic mitochondrial energy impairment produces selective striatal degeneration and abnormal choreiform movements in primates. Proc. Natl. Acad. Sci. USA 92, 7105-7109.
11. Buisson A., Callebert J., Mathieu E., Plotkine M., and Boulu R. G. (1992) Striatal protection induced by lesioning the substantia nigra of rats subjected to focal ischemia. J. Neurochem. 59, 1153-1157.
12. Chan P., Di Monte D. A., Luo J.-J., DeLanney L. E., Irwin I., and Langston J. W. (1994) Rapid ATP loss caused by methamphetamine in mouse striatum: relationship between energy impairment and dopaminergic neurotoxicity. J. Neurochem. 62, 2484-2487.
13. Cheng N., Maeda T., Kume T., Kaneko S., Kochiyama H., Akaike A., Goshima Y., and Misu Y. (1996) Differential neurotoxicity induced by L-DOPA and dopamine in cultured striatal neurons. Brain Res. 743, 278-283.
14. Chesselet M.-F., Gonzales C., Lin C. S., Polsky K., and Jin B. K. (1990) Ischemic damage in the striatum of adult gerbils: relative sparing of somatostatin and cholinergic interneurons contrasts with loss of efferent neurons. Exp. Neural. 110, 209-218.
15. Chiueh C. C., Miyake J., and Peng M. T. (1993) Role of dopamine autoxidation, hydroxyl radical generation, and calcium overload in underlying mechanisms involved in MPTP induced parkinsonism. Adv. Neurol. 60, 251-258.
16. Clemens J. A. and Phebus L. A. (1988) Dopamine depletion protects striatal neurons from ischemia-induced cell death. Life Sci. 42, 707-713.
17. Dutra J. C., Dutra-Filho C. S., Cardozo S. E. C., Wannmacheer C. M. D., Sarkis J. J. F., and Wajner M. (1993) Inhibition of succinate dehydrogenase and β-hydroxybutyrate dehydrogenase activities by methylmalonate in brain and liver of developing rats. J. Inherit. Metab. Dis. 16, 147-153.
18. Erecińska M. and Nelson D. (1994) Effects of 3-nitropropionic acid on synaptosomal energy and transmitter metabolism: relevance to neurodegenerative brain diseases. J. Neurochem. 63, 1033-1041.
19. Erecińska M. and Silver I. A. (1989) ATP and brain function. J. Cereb. Blood Flow Metab. 9, 2-19.
20. Ferrante R. J., Kowall N. W., Beal M. F., Richardson E. P., Bird E. D., and Martin J. B. (1985) Selective sparing of a class of striatal neurons in Huntington's disease. Science 230, 561-563.
21. Filloux F. and Townsend J. J. (1993) Pre- and postsynaptic neurotoxic effects of dopamine demonstrated by intrastriatal injection. Exp. Neurol. 119, 79-88.
22. Gabby M., Tauber M., Porat S., and Simantov R. (1996) Selective role of glutathione in protecting human neuronal cells from dopamine-induced apoptosis. Neuropharmacology 35, 571-578.
23. Globus M. Y.-T., Busto R., Dietrich W. D., Martinez E., Valdes I., and Ginsberg M. D. (1988) Effect of ischemia on the in vivo release of striatal dopamine, glutamate, and γ-aminobutyric acid studied by intracerebral microdialysis. J. Neurochem. 51, 1455-1464.
24. Graham D. G. (1984) Catecholamine toxicity: a proposal for the molecular pathogenesis of manganese neurotoxicity and Parkinson's disease. Neurotoxicology 5, 83-96.
25. Graham D. G., Tiffany S. M., Bell W. R., and Gutnecht W. F. (1978) Autoxidation versus covalent binding of quinones as the mechanism of toxicity of dopamine, 6-hydroxydopamine, and related compounds toward c1300 neuroblastoma cells in vitro. Mol. Pharmacol. 14, 644-653.
26. Graveland G. A., Williams R. S., and DiFiglia M. S. (1985) Evidence for degenerative and regenerative changes in neostriatal spiny neurons in Huntington's disease. Science 227, 770-773.
27. Greene J. G., Porter R. H. P., Eller R. V., and Greenamyre J. T. (1993) Inhibition of succinate dehydrogenase by malonic acid produces an "excitotoxic" lesion in rat striatum. J. Neurochem. 61, 1151-1154.
28. Hartzell H. C., Mery P. F., Fischmeister R., and Szabo G. (1991) Sympathetic regulation of cardiac calcium current is due exclusively to cAMP-dependent phosphorylation. Nature 351, 573-576.
29. 3H]-dopamine: impact of ascorbic acid and glutathione. J. Neurochem. 63, 1126-1132.
30. Hastings T. G., Lewis D. A., and Zigmond M. J. (1996) Role of oxidation in the neurotoxic effects of intrastriatal dopamine injections. Proc. Natl. Acad. Sci. USA 93, 1956-1961.
31. Hoyt K. R., Reynolds I. J., and Hastings T. G. (1997) Mechanisms of dopamine-induced cell death in cultured rat forebrain neurons: interactions with and differences from glutamate-induced cell death. Exp. Neurol 143, 269-281.
32. Jackson D. M. and Westlind-Danielsson A. (1994) Dopamine receptors: molecular biology, biochemistry, and behavioral aspects. Pharmacol. Ther. 64, 291-369.
33. Ludolph A. C., He F., Spencer P. S., Hammerstad J., and Sabri M. (1991) 3 Nitropropionic acid - exogenous animal neurotoxin and possible human striatal toxin. Can. J. Neurol. Sci. 18, 492-498.
34. Ludolph A. C., Seelig M., Ludolph A., Novitt P., Allen C. N., Spencer P.S., and Sabri M.I. (1992) 3-Nitropropionic acid decreases cellular energy levels and causes neuronal degeneration in cortical explants. Neurodegeneration 1, 155-161.
35. Maker H. S., Weiss C., and Brannan T. S. (1986) Amine-mediated toxicity. The effects of dopamine, norepinephrine, 5-hydroxytryptamine, 6-hydroxydopamine, ascorbate, glutathione and peroxide on the in vitro activities of creatine and adenylate kinases in the brain of the rat. Neuropharmacology 25, 25-32.
36. McConkey D. J. and Orrenius S. (1996) The role of calcium in the regulation of apoptosis. J. Leukocyte Biol. 59, 774-783.
37. McLaughlin B. A., Nelson D., Silver I., Erecińska M., and Chesselet M.-F. (1998) Methyl malonate toxicity in primary neuronal cultures. Neuroscience (in press).
38. Michel P. P. and Hefti F. (1990) Toxicity of 6-hydroxydopamine and dopamine for dopaminergic neurons in culture. J. Neurosci. Res. 26, 428-435.
39. Mills J.C., Nelson D., Ereciriska M., and Pittman R. N. (1995) Metabolic and energetic changes during apoptosis in neural cells. J. Neurochem. 65, 1721-1730.
40. Morikawa N., Nakagawa-Hattori Y., and Mizuno Y. (1996) Effect of dopamine, dimethoxyphenylethylamine, papaverine, and related compounds on mitochondrial respiration and complex I activity. J. Neurochem. 66, 1174-1181.
41. Offen D., Ziv I., Gorodin S., Barzilai A., Malik Z., and Melamed E. (1995) Dopamine-induced programmed cell death in mouse thymocytes. Biochim. Biophys. Acta 1268, 171-177.
42. Offen D., Ziv I., Sternin H., Melamed E., and Hochman A. (1996) Prevention of dopamine-induced cell death by thiol antioxidants: possible implications for treatment of Parkinson's disease. Exp. Neurol. 141, 32-39.
43. Palfi S., Ferrante R. J., Brouillet E., Beal M. F., Dolan R., Guyot M. C., Peschanski M., and Hantraye P. (1996) Chronic 3-nitropropionic acid treatment in baboons replicates the cognitive and motor deficits of Huntington's disease. J. Neurosci. 16, 3019-3025.
44. Pang Z. and Geddes J. W. (1997) Mechanisms of cell death induced by the mitochondrial toxin 3-nitropropionic acid: acute excitotoxic necrosis and delayed apoptosis. J. Neurosci. 17, 3064-3073.
45. Parker W. D. Jr., Boyson S. J., and Parks J. K. (1989) Abnormalities in the electron transport chain in idiopathic Parkinson's disease. Ann. Neurol. 26, 719-723.
46. Phebus L. A., Perry K. W., Clemens J. A., and Fuller R. W. (1986) Brain anoxia releases striatal dopamine in rats. Life Sci. 38, 2447-2453.
47. Pittman R. N., Wang S., DiBenedetto A. J., and Mills J. C. (1993) A system for characterizing cellular and molecular events in programmed neuronal cell death. J. Neurosci. 13, 3669-3680.
48. Reed J. C. (1997) Cytochrome c: can't live with it - can't live without it. Cell 91, 559-562.
49. Rosenberg P. A. (1988) Catacholamine toxicity in cerebral cortex of dissociated cell culture. J. Neurosci. 8, 2887-2894.
50. 2-dopamine receptors on arachidonic acid release and cyclic AMP production in striatal neurons. J. Neurochem. 62, 944-949.
51. Seiden L. S. and Vosmer G. (1984) Formation of 6-hydroxydopamine in caudate nucleus of the rat brain after a single large dose of methylamphetamine. Pharmacol. Biochem. Behav. 21, 29-31.
52. Simantov R., Blinder E., Ratovitski T., Tauber M., Gabbay M., and Porat S. (1996) Dopamine-induced apoptosis in human neuronal cells: inhibition by nucleic acids antisense to the dopamine transporter. Neuroscience 74, 39-50.
53. Slivka A., Brannan T. S., Weinberger J., Knott P. J., and Cohen G. (1988) Increase in extracellular dopamine in the striatum during cerebral ischemia: a study utilizing cerebral microdialysis. J. Neurochem. 50, 1714-1718.
54. Spina M. B. and Cohen G. (1989) Dopamine turnover and glutathione oxidation: implications for Parkinson disease. Proc. Natl. Acad. Sci. USA 86, 1398-1400.
55. Trautwein W. and Hescheler J. (1990) Regulation of cardiac L-type calcium current by phosphorylation and G proteins. Annu. Rev. Physiol. 52, 257-274.
56. Weiss S., Sebben M., Garcia-Sainz J. A., and Bockaert J. (1985) D2-dopamine receptor mediated inhibition of cyclic AMP formation in striatal neurons in primary culture. Mol. Pharmacol. 27, 595-599.
57. Yamamoto Y., Tanaka T., Shibata S., and Watanabe S. (1994) Involvement of D1 dopamine receptor mechanism in ischemia-induced impairment of CA1 presynaptic fiber spikes in rat hippocampal slices. Brain Res. 665, 151-154.
58. Yao H., Sadoshima S., Ishitsuka T., Nagao T., Fujishima M., Tsutsumi T., and Uchimura H. (1988) Massive striatal dopamine release in acute cerebral ischemia in rats. Experientia 44, 506-508.
59. Zamzami N., Marchetti P., Castedo M., Decaudin D., Macho A., Hirsch T., Susin S. A., Petit P. X., Mignotte B., and Kroemer G. (1995) Sequential reduction of mitochondrial transmembrane potential and generation of reactive oxygen species in early programmed cell death. J. Exp. Med. 182, 367-377.
60. Zilkha-Falb R., Ziv I., Nardi N., Offen D., Melamed E., and Barzilai A. (1997) Monoamine-induced apoptotic neuronal cell death. Cell. Mol. Neurobiol 17, 101-118.
61. Ziv I., Melamed E., Nardi N., Luria D., Achiron A., Offen D., and Barzilai A. (1994) Dopamine induces apoptosis-like cell death in cultured chick sympathetic neurons - a possible novel pathogenetic mechanism in Parkinson's disease. Neurosci. Lett. 170, 136-140.